Regenerated Cell Therapy for Stress Urinary Incontinence: A Meta-Analysis

Huang, Zhuowei; Yang, Tianen; Shao, Lishi; Yang, Bowei; Yang, Shunhang; Wang, Guang; Li, Pei; Li, Jiongming

doi:10.1080/08941939.2020.1805654

Cited by 3 publications

(3 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Academic discourse is getting more circumspect and rigorous, and lower urinary tract terminology is likewise becoming more standardized. In the aspect of the treatment methods, bladder neck suspension was first studied [ 64 ], followed by the insights of surgery [ 65 ], cell therapy [ 66 ] and muscle training [ 67 ]. Concentration on the study of acupuncture therapy only started in the recent decade.…”

Section: Discussionmentioning

confidence: 99%

Research trends of acupuncture therapy on stress urinary incontinence from 1992 to 2022: A bibliometric analysis

Wu,

Li,

Shi

et al. 2023

Heliyon

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Research trends of acupuncture therapy on stress urinary incontinence from 1992 to 2022: A bibliometric analysis

Wu,

Li,

Shi

et al. 2023

Heliyon

View full text Add to dashboard Cite

“…22 A second large meta-analysis of 23 studies with a total of 890 male and female patients reported results for women separately. 23 Neither study reported comparators, outcomes, or outcome data in the abstract, rendering the ability to draw meaningful support for SCT unclear. However, Klapper-Goldstein concluded that SCT is a safe and effective treatment for SUI, 22 and Huang reported a 26% pooled complication rate for females with no serious complications.…”

Section: Sis Versus Tmusmentioning

confidence: 99%

“…However, Klapper-Goldstein concluded that SCT is a safe and effective treatment for SUI, 22 and Huang reported a 26% pooled complication rate for females with no serious complications. 23…”

Section: Treatmentmentioning

confidence: 99%

Updates to Surgical Treatment of Female Stress Urinary Incontinence (SUI): AUA/SUFU Guideline (2023)

et al. 2023

View full text Add to dashboard Cite

Purpose: The purpose of this guideline is to provide a clinical structure with which to approach the diagnosis, counseling, and treatment of female patients with stress urinary incontinence (SUI). Materials/Methods: The primary source of evidence for the 2017 version of the SUI guideline was the systematic literature review conducted by the ECRI Institute. The initial search spanned literature from January 2005 to December 2015, with an additional updated abstract search through September 2016. The current amendment represents the first update to the 2017 iteration and includes updated literature published through February 2022. Results: This guideline has been amended to reflect changes in and additions to the literature since 2017. The Panel maintained that the differentiation between index and non-index patients remained important. The index patient is a healthy female with minimal or no prolapse who desires surgical therapy for treatment of pure SUI or stress-predominant mixed urinary incontinence. Non-index patients have factors that may affect their treatment options and outcomes, such as high grade prolapse (grade 3 or 4), urgency-predominant mixed incontinence, neurogenic lower urinary tract dysfunction, incomplete bladder emptying, dysfunctional voiding, SUI following anti-incontinence treatment, mesh complications, high body mass index, or advanced age. Conclusion: While gains have been made in the field to support new methods for the diagnosis, treatment, and follow-up of patients with SUI, the field continues to expand. As such, future reviews of this guideline will take place to stay in keeping with the highest levels of patient care.

show abstract